| Literature DB >> 30126107 |
Ting-Min Hsieh1, Pao-Jen Kuo2, Shiun-Yuan Hsu3, Peng-Chen Chien4, Hsiao-Yun Hsieh5, Ching-Hua Hsieh6.
Abstract
This study aimed to assess whether hypothermia is an independent predictor of mortality in trauma patients in the condition of defining hypothermia as body temperatures of <36 °C. Data of all hospitalized adult trauma patients recorded in the Trauma Registry System at a level I trauma center between 1 January 2009 and 12 December 2015 were retrospectively reviewed. A multivariate logistic regression analysis was performed in order to identify factors related to mortality. In addition, hypothermia and normothermia were defined as temperatures <36 °C and from 36 °C to 38 °C, respectively. Propensity score-matched study groups of hypothermia and normothermia patients in a 1:1 ratio were grouped for mortality assessment after adjusting for potential confounders such as age, sex, preexisting comorbidities, and injury severity score (ISS). Of 23,705 enrolled patients, a total of 401 hypothermic patients and 13,368 normothermic patients were included in this study. Only 3.0% of patients had hypothermia upon arrival at the emergency department (ED). Compared to normothermic patients, hypothermic patients had a significantly higher rate of abbreviated injury scale (AIS) scores of ≥3 in the head/neck, thorax, and abdomen and higher ISS. The mortality rate in hypothermic patients was significantly higher than that in normothermic patients (13.5% vs. 2.3%, odds ratio (OR): 6.6, 95% confidence interval (CI): 4.86⁻9.01, p < 0.001). Of the 399 well-balanced propensity score-matched pairs, there was no significant difference in mortality (13.0% vs. 9.3%, OR: 1.5, 95% CI: 0.94⁻2.29, p = 0.115). However, multivariate logistic regression analysis revealed that patients with low body temperature were significantly associated with the mortality outcome. This study revealed that low body temperature is associated with the mortality outcome in the multivariate logistic regression analysis but not in the propensity score matching (PSM) model that compared patients with hypothermia defined as body temperatures of <36 °C to those who had normothermia. These contradicting observations indicated the limitation of the traditional definition of body temperature for the diagnosis of hypothermia. Prospective randomized control trials are needed to determine the relationship between hypothermia following trauma and the clinical outcome.Entities:
Keywords: coagulopathy; emergency department (ED); hypothermia; mortality
Mesh:
Year: 2018 PMID: 30126107 PMCID: PMC6121888 DOI: 10.3390/ijerph15081769
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flowchart of patient selection from the Trauma Registry System.
Demographics and admission characteristics of the study groups.
| Variables | Hypothermia | Normothermia | Odds Ratio |
| |||
|---|---|---|---|---|---|---|---|
| Sex, | <0.001 | ||||||
| Male | 260 | (64.8) | 7455 | (55.8) | 1.5 | (1.19–1.80) | |
| Female | 141 | (35.2) | 5913 | (44.2) | 0.7 | (0.56–0.84) | |
| Age (years) | 53.3 | ±19.0 | 54.3 | ±19.4 | — | 0.293 | |
| Comorbidity, | |||||||
| HTN | 99 | (24.7) | 3972 | (29.7) | 0.8 | (0.62–0.98) | 0.030 |
| DM | 59 | (14.7) | 2119 | (15.9) | 0.9 | (0.69–1.21) | 0.579 |
| CVA | 13 | (3.2) | 589 | (4.4) | 0.7 | (0.42–1.27) | 0.270 |
| CAD | 16 | (4.0) | 554 | (4.1) | 1.0 | (0.58–1.60) | 0.901 |
| CHF | 5 | (1.2) | 125 | (0.9) | 1.3 | (0.54–3.29) | 0.594 |
| ESRD | 11 | (2.7) | 288 | (2.2) | 1.3 | (0.70–2.36) | 0.484 |
| BAC ≥ 50 mg/dL, | 60 | (15.0) | 871 | (6.5) | 2.5 | (1.90–3.35) | <0.001 |
| Alcohol level (mg/dL) | 213.0 | ±90.4 | 187.1 | ±73.3 | — | 0.010 | |
| SBP (mmHg) | 137.8 | ±46.0 | 151.4 | ±34.2 | — | <0.001 | |
| SBP ≤ 60 mmHg, | 18 | (4.5) | 45 | (0.3) | 13.9 | (7.98–24.26) | <0.001 |
| SBP ≤ 90 mmHg, | 46 | (11.5) | 307 | (2.3) | 5.5 | (3.97–7.65) | <0.001 |
| HR (beats/min) | 83.9 | ±26.4 | 86.3 | ±17.4 | — | 0.109 | |
| RR (times/min) | 18.7 | ±5.0 | 18.6 | ±2.0 | — | 0.741 | |
| Mechanism, | |||||||
| Driver of MV | 16 | (4.0) | 224 | (1.7) | 2.4 | (1.45–4.09) | 0.002 |
| Passenger of MV | 5 | (1.2) | 97 | (0.7) | 1.7 | (0.70–4.27) | 0.225 |
| Driver of motorcycle | 195 | (48.6) | 5380 | (40.2) | 1.4 | (1.15–1.72) | <0.001 |
| Passenger of motorcycle | 4 | (1.0) | 270 | (2.0) | 0.5 | (0.18–1.32) | 0.200 |
| Bicyclist | 18 | (4.5) | 506 | (3.8) | 1.2 | (0.74–1.93) | 0.506 |
| Pedestrian | 7 | (1.7) | 277 | (2.1) | 0.8 | (0.39–1.79) | 0.727 |
| Fall | 96 | (23.9) | 4611 | (34.5) | 0.6 | (0.47–0.75) | <0.001 |
| Penetrating injury | 11 | (2.7) | 563 | (4.2) | 0.6 | (0.35–1.18) | 0.163 |
| Blunt injury | 28 | (7.0) | 1168 | (8.7) | 0.8 | (0.53–1.16) | 0.242 |
| Strike by/against | 21 | (5.2) | 272 | (2.0) | 2.7 | (1.69–4.20) | <0.001 |
| GCS | 12.2 | ±4.5 | 14.2 | ±2.3 | — | <0.001 | |
| ≤8 | 89 | (22.2) | 688 | (5.1) | 5.3 | (4.10–6.74) | <0.001 |
| 9–12 | 29 | (7.2) | 551 | (4.7) | 1.8 | (1.23–2.67) | 0.003 |
| ≥13 | 283 | (70.6) | 12,129 | (90.1) | 0.2 | (0.20–0.31) | <0.001 |
| AIS ≥ 3 | |||||||
| Head/neck | 154 | (38.4) | 2728 | (20.4) | 2.4 | (1.98–2.99) | <0.001 |
| Face | 1 | (0.2) | 33 | (0.2) | 1.0 | (0.14–7.41) | 1.000 |
| Thorax | 50 | (12.5) | 855 | (6.4) | 2.1 | (1.54–2.83) | <0.001 |
| Abdomen | 18 | (4.5) | 339 | (2.5) | 1.8 | (1.11–2.93) | 0.019 |
| Extremity | 105 | (26.2) | 4321 | (32.3) | 0.7 | (0.59–0.93) | 0.011 |
| ISS (median, IQR) | 10 | (5–20) | 9 | (4–10) | — | <0.001 | |
| <16 | 236 | (58.9) | 10,929 | (81.8) | 0.3 | (0.26–0.39) | <0.001 |
| 16–24 | 86 | (21.4) | 1712 | (12.8) | 1.9 | (1.46–2.37) | <0.001 |
| ≥25 | 79 | (19.7) | 727 | (5.4) | 4.3 | (3.30–5.52) | <0.001 |
| Mortality, | 54 | (13.5) | 307 | (2.3) | 6.6 | (4.86–9.01) | <0.001 |
| Hospital LOS (days) | 12.4 | ±12.9 | 10.1 | ±10.8 | — | 0.001 | |
| ICU admission, | 175 | (43.6) | 2858 | (21.4) | 2.8 | (2.33–3.48) | <0.001 |
Data are presented as means ± SD, median (IQR), or n (%). HTN, hypertension; DM, diabetic mellitus; CVA, cerebral vascular accident; CAD, coronary artery disease; CHF, congestive heart failure; ESRD, end-stage renal disease; BAC, blood alcohol concentration; SBP, systolic blood pressure; HR, heart rate; RR, respiratory rate; MV, motor vehicle; GCS, Glasgow coma score; AIS, abbreviated injury scale; ISS, injury severity scale; LOS, length of stay; ICU, intensive care unit.
Comparison of biochemistry between study groups.
| Variables | Hypothermia | Normothermia | Odds Ratio |
| ||
|---|---|---|---|---|---|---|
| Hemoglobin (g/dL) | 12.8 | ±2.5 | 13.1 | ±2.1 | — | 0.016 |
| Hematocrit (%) | 38.0 | ±6.9 | 38.8 | ±6.4 | — | 0.022 |
| PT (seconds) | 11.7 | ±4.7 | 10.9 | ±2.6 | — | <0.001 |
| aPTT (seconds) | 29.6 | ±12.0 | 27.3 | ±4.4 | — | <0.001 |
Data are presented as means ± SD. PT, prothrombin time; aPTT, activated partial thromboplastic time.
Correlation of biochemistry to temperature in study population.
| Variables | Pearson Correlation |
|
|---|---|---|
| Hemoglobin (g/dL) | −0.011 | 0.067 |
| Hematocrit (%) | −0.016 | 0.067 |
| PT (seconds) | −0.035 | <0.001 |
| aPTT (seconds) | −0.068 | <0.001 |
PT, prothrombin time; aPTT, activated partial thromboplastic time.
Figure 2Pearson correlation of levels of hemoglobin (Hb) (A), hematocrit (Hct) (B), prothrombin time (PT) (C), and activated partial thromboplastin time (aPTT) (D) to the body temperature.
Comparison of variable between fatal and survival patient groups.
| Variables | Mortality | Survival |
| ||
|---|---|---|---|---|---|
| Gender, | <0.001 | ||||
| Male | 241 | (66.8) | 7474 | (55.7) | |
| Female | 120 | (33.2) | 5934 | (44.3) | |
| Age (years) | 60.4 | ±19.7 | 54.1 | ±19.3 | <0.001 |
| Co-morbidity, | |||||
| HTN | 118 | (32.7) | 3953 | (29.5) | 0.198 |
| DM | 61 | (16.9) | 2117 | (15.8) | 0.609 |
| CVA | 22 | (6.1) | 580 | (4.3) | 0.116 |
| CAD | 26 | (7.2) | 544 | (4.1) | 0.005 |
| CHF | 8 | (2.2) | 122 | (0.9) | 0.021 |
| ESRD | 22 | (6.1) | 277 | (2.1) | <0.001 |
| Temperature (°C) | 36.0 | ±2.8 | 36.5 | ±0.6 | 0.002 |
| SBP (mmHg) | 144.6 | ±57.0 | 151.2 | ±33.8 | 0.029 |
| HR (beats/min) | 47.8 | ±35.0 | 65.5 | ±29.4 | <0.001 |
| RR (times/min) | 18.5 | ±6.0 | 18.6 | ±1.9 | 0.661 |
| ISS (median, IQR) | 25 | (17–30) | 9 | (4–10) | <0.001 |
Data are presented as means ± SD, median (IQR), or n (%). HTN, hypertension; DM, diabetic mellitus; CVA, cerebral vascular accident; CAD, coronary artery disease; CHF, congestive heart failure; ESRD, end-stage renal disease; SBP, systolic blood pressure; HR, heart rate; RR, respiratory rate; ISS, injury severity scale.
Variables related to mortality of the patients in multivariate logistic regression.
| Variables | Odds Ratio | (95% CI) |
|
|---|---|---|---|
| Male | 1.72 | 1.32–2.24 | <0.001 |
| Age | 1.04 | 1.03–1.04 | <0.001 |
| CHF | 2.71 | 1.24–5.92 | 0.012 |
| ESRD | 3.69 | 2.23–6.11 | <0.001 |
| Temperature (°C) | 0.66 | 0.54–0.80 | 0.002 |
| HR (beats/min) | 0.99 | 0.99–0.99 | <0.001 |
| ISS (median, IQR) | 1.17 | 1.16–1.19 | <0.001 |
CHF, congestive heart failure; ESRD, end-stage renal disease; HR, heart rate; ISS, injury severity scale.
Comparison of outcomes between study groups before and after propensity score matching.
| Varibles | Before | After | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hypothermia | Normothermia |
|
| Hypothermia | Normothermia |
|
| |||||||
| Sex, | 1.000 | |||||||||||||
| Male | 260 | (64.8) | 7455 | (55.8) | 1.5 | (1.19–1.80) |
| 258 | (64.7) | 258 | (64.7) | 1.0 | (0.75–1.34) | |
| Female | 141 | (35.2) | 5913 | (44.2) | 0.7 | (0.56–0.84) |
| 141 | (35.3) | 141 | (35.3) | 1.0 | (0.75–1.34) | |
| Age (years) | 53.3 | ±19.0 | 54.3 | ±19.4 | — |
| 53.2 | ±19.0 | 53.1 | ±19.2 | — | 0.969 | ||
| Comorbidity, | ||||||||||||||
| HTN | 99 | (24.7) | 3972 | (29.7) | 0.8 | (0.62–0.98) |
| 98 | (24.6) | 98 | (24.6) | 1.0 | (0.72–1.38) | 1.000 |
| DM | 59 | (14.7) | 2119 | (15.9) | 0.9 | (0.69–1.21) |
| 57 | (14.3) | 57 | (14.3) | 1.0 | (0.67–1.49) | 1.000 |
| CVA | 13 | (3.2) | 589 | (4.4) | 0.7 | (0.42–1.27) |
| 13 | (3.3) | 13 | (3.3) | 1.0 | (0.46–2.19) | 1.000 |
| CAD | 16 | (4.0) | 554 | (4.1) | 1.0 | (0.58–1.60) |
| 15 | (3.8) | 15 | (3.8) | 1.0 | (0.48–2.07) | 1.000 |
| CHF | 5 | (1.2) | 125 | (0.9) | 1.3 | (0.54–3.29) |
| 5 | (1.3) | 5 | (1.3) | 1.0 | (0.29–3.48) | 1.000 |
| ESRD | 11 | (2.7) | 288 | (2.2) | 1.3 | (0.70–2.36) |
| 11 | (2.8) | 11 | (2.8) | 1.0 | (0.43–2.33) | 1.000 |
| ISS (median, IQR) | 10 | (5–20) | 9 | (4–10) | — |
| 10 | (5–20) | 10 | (5–20) | — | 0.950 | ||
| Mortality, | 54 | (13.5) | 307 | (2.3) | 6.6 | (4.86–9.01) |
| 52 | (13.0) | 37 | (9.3) | 1.5 | (0.94–2.29) | 0.115 |
| LOS in hospital (days) | 12.4 | ±12.9 | 10.1 | ±10.8 | — |
| 12.4 | ±12.9 | 12.8 | ±13.7 | — | 0.662 | ||
| ICU admission, | 175 | (43.6) | 2858 | (21.4) | 2.8 | (2.33–3.48) |
| 173 | (43.4) | 159 | (39.8) | 1.2 | (0.87–1.53) | 0.350 |
| PT (seconds) | 11.7 | ±4.7 | 10.9 | ±2.6 | — |
| 11.2 | ±2.9 | 11.3 | ±9.6 | — | 0.812 | ||
| aPTT (seconds) | 29.6 | ±12.0 | 27.3 | ±4.4 | — |
| 28.3 | ±9.6 | 27.6 | ±5.0 | — | 0.145 | ||
Data are presented as means ± SD, median (IQR), or n (%). HTN, hypertension; DM, diabetic mellitus; CVA, cerebral vascular accident; CAD, coronary artery disease; CHF, congestive heart failure; ESRD, end-stage renal disease; ISS, injury severity scale; LOS, length of stay; ICU, intensive care unit; PT, prothrombin time; aPTT, activated partial thromboplastic time.